Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos

Inclusion Criteria: * Both sexes. * Age between 18 and 50. * Available for follow-up during the period of the study * Willing to provide their name, address, telephone number and other information by each they can be contact for the study learn if necessary (eg in case of lack the scheduled visit). * Willing to strictly follow the study protocol. * Ability to understand and signing the consent form. * Understanding the impossibility to participate in another clinical trial during the time which is participating in the study. * Intellectual level that allows filling in the forms for registration of symptoms at home. * Acceptance for serological testing for human immunodeficiency virus (HIV), Hepatitis B virus (HBV) and Hepatitis C virus (HCV). * Be in good health, with no significant medical history. * Physical examination screening without significant clinical changes. * Screening laboratory tests within normal limits established the laboratory or abnormal values smaller than 1 degree. * Additional criterion for females: Negative pregnancy test before application of the vaccine dose, for women of childbearing age. Exclusion Criteria: \- Pregnant or breast-feeding. Personal history of: * Meningitis of any kind. * Serious adverse reaction to any vaccination, such as difficulty breathing, angioedema and anaphylaxis. * Severe adverse reaction related to prior immunization with tetanus and / or diphtheria vaccines alone or in combination vaccines. * Vaccination with tetanus a…